SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001999371-24-003168
Filing Date
2024-03-06
Accepted
2024-03-06 17:01:16
Documents
1
Period of Report
2024-02-27

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP ownership.html 4/A  
1 AMENDMENT TO STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP ownership.xml 4/A 8760
  Complete submission text file 0001999371-24-003168.txt   10377
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
LEDERMAN SETH (Reporting) CIK: 0001563420 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36019 | Film No.: 24726827